Navigation Links
Ventas Appoints James D. Shelton and Robert D. Reed to Board
Date:3/5/2008

g plans, business strategy, budgets, projected costs, capital expenditures, competitive positions, acquisitions, investment opportunities, merger integration, growth opportunities, expected lease income, continued qualification as a real estate investment trust ("REIT"), plans and objectives of management for future operations and statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will" and other similar expressions are forward-looking statements. Such forward-looking statements are inherently uncertain, and security holders must recognize that actual results may differ from the Company's expectations. The Company does not undertake a duty to update such forward-looking statements, which speak only as of the date on which they are made.

The Company's actual future results and trends may differ materially depending on a variety of factors discussed in the Company's filings with the Securities and Exchange Commission. Factors that may affect the Company's plans or results include without limitation: (a) the ability and willingness of the Company's operators, tenants, borrowers, managers and other third parties, as applicable, to meet and/or perform the obligations under their various contractual arrangements with the Company; (b) the ability and willingness of Kindred Healthcare, Inc. (together with its subsidiaries, "Kindred"), Brookdale Living Communities, Inc. (together with its subsidiaries, "Brookdale") and Alterra Healthcare Corporation (together with its subsidiaries, "Alterra") to meet and/or perform their obligations to indemnify, defend and hold the Company harmless from and against various claims, litigation and liabilities under the Company's respective contractual arrangements with Kindred, Brookdale and Alterra; (c) the ability of the Company's operators, tenants, borrowers and managers, as applicable, to maintain the financial strength and liquidity necessary to
'/>"/>

SOURCE Ventas, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ventas to Present at the Citi 2008 Global Property CEO Conference
2. Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69
3. Ventas Completes Previously Announced Sale of Common Stock
4. Ventas Enters Agreement to Sell Common Stock
5. Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance
6. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
7. Ventas Appoints Brush SVP - Senior Housing Development and Operations
8. Ventas Announces 2007 Third Quarter Earnings Release Date and Conference Call
9. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
10. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
11. Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...e University College of Medicine research team led...layer of regulation in the cell division cycle, wh...ay cancer begins. , Wang, an assistant professor..., said the findings will lead to an improved abili... of new drugs that kill cancer cells by inhibiting...
(Date:11/21/2008)...ewswire/ -- The Generic,Pharmaceutical Associatio...om,GPhA President and CEO Kathleen Jaeger regardi...on "Emerging Health Care Competition and Consumer ...onducting this roundtable demonstrates the,growin...ess to safe and,affordable biogenerics sooner rat...
(Date:11/21/2008)...USNewswire/ -- New research at West Virginia Univ... tobacco product aimed at young adults is catching...ds, Camel Snus - touted as a socially acceptable w...gh levels of nicotine. , , "Camel Snus cont..." said Bruce Adkins of the state Division of Tobac...
(Date:11/21/2008)...re-FirstCall/ -- Today, prescription drugs are the... 88 percent of patients suffering chronic conditio...onic condition account for 96 percent of all presc...l costs. A proprietary new pharmacy model develop.... (NYSE: MHS ) significantly reduces critical ga...
Breaking Medicine News(10 mins):Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6
...h officials are all set to oil the wheels of retai...opose new regulations to allow for the operation o...lso encourage not-for-profit hospitals, community ... basic medical services. The proposed changes wer...
...ntified the first gene that is linked to Restless ...er that affects millions of people worldwide . RL...ering need to move the legs and is also a major ca...sleep disturbance. We now have concrete evidence t...
...from heart disease among younger Britons is slowin... research published ahead of print in the journal ...nary artery heart disease in England and Wales bet...gures.They used the data to calculate heart diseas...
...f more than a thousand prisoners has failed to sol...e and prisoner rehabilitation programmes, said th...niversary of the Ministry of Justices introduction...lleviate the overcrowding crisis in English and We...
Other Medicine News:Health News:Retail Health Clinics Start Shop 2Health News:Gene Linked With Restless Leg Syndrome Spotted Out 2Health News:Disquieting Slow Down in Heart Disease Deaths Among Under 55s 2Health News:Prison Healthcare Continues to Fail Despite Emergency Measures, Warns BMA 2
(Date:11/19/2008)... Calif., Nov. 19 Amgen,...ogy Company, a subsidiary of,Takeda Pharmaceutica...t,enrollment in the Phase 3 MONET1 trial evaluati...axel and carboplatin for the first-line treatment ...s been temporarily suspended,following a planned ...
(Date:11/19/2008)...illion Payment from Roche- , , MONTVALE, N....aceuticals Corp. (Nasdaq: MEMY ) today announced...Phase 2 trial of R3487/MEM 3454, its lead alpha-7 ...t associated with schizophrenia (CIAS). The Compa...l, triggering a $5.0 million payment from its part...
(Date:11/18/2008)...Association,s 2008 Faces of Influenza survey under... against influenza; Mother and Gold Medalist Krist...N, Nov. 18 While 78 percent of mot...ere and potentially life-threatening disease that ...r families will get vaccinated this season, accord...
(Date:11/12/2008)...Nov. 12 A new study bei...ll will help answer the,question, what causes Park...ons in the medical research into,Parkinson,s disea... to die,in the first place. Answering this questio...two nearly identical types of brain cells that pro...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6A Window Into Parkinson's Disease 2Inside Myanmar 3A California Relief Organization Bypasses Bureaucratic Barriers Has Aid Workers in Myanmar 18991 1Air Methods Corporation Confirms Fatal Accident in Wisconsin 18988 116th Annual Komen Pittsburgh Race for the Cure 28R 29 Winners Announced 18986 116th Annual Komen Pittsburgh Race for the Cure 28R 29 Winners Announced 18986 2A new gene trigger for pregnancy disorder identified 3261 1A new gene trigger for pregnancy disorder identified 3261 2
...g Editor Harvard Medical School ,The FDA ap...can patients has underscored the concept that two ...ation. This concept holds true for a wide variety... to individual genetic variations. As the field of...e new laboratory tools have arrived to help clinic...
...rst human case of West Nile virus (WNV) for 2005 w...e. The CDC has released few details on the patien...nted incidence of the mosquito borne disease in th...lavivirus of about 11 kb. It primarily infects bi... vertebrates serving as incidental hosts. The vir...
Other Medicine Technology:Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 2Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 3West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 2West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 3West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 4
Healon vitreous aspirating cannula, 21 gauge.
Flexible silicone tip cannula allows atraumatic access through retinal tear or hole for aspiration of subretinal fluids. Silicone tube extends 6mm beyond end of cannula. Luer lock hub for easy, sec
Ultra thin wall .90 mm (20 g) cannula allows maximum flow rate, 6 mm in length. Cannula beveled for easy insertion through sclerotomy. 3201 has 16 cm (6 in) high pressure PVC tubing to allow injectio
...ective line of compact CO2 systems combines portab...ature an extremely accurate laser beam, as well as...cially advantageous for small operating theatres a.... Use of special contact tips and accessories allo...
Medicine Products: